Connor, Clark & Lunn Investment Management Ltd.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1596800
VANCOUVER, A1
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,478,625
+$1,627,433 QoQ
Shares Held
42,465
+32.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#176
of 1,322 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $650,455,382 across 105 Biotechnology names. REGN ranks #5 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in REGN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,478,625 | 42,465 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,851,192 | 32,164 | Shares | Sole | 2026-05-11 | |
| 2025-03-31 | $1,215,818 | 1,917 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $665,316 | 934 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,561,983 | 20,511 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $9,987,938 | 9,503 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,925,942 | 2,001 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,919,941 | 2,186 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,194,011 | 2,666 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,181,408 | 16,953 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $24,475,084 | 29,787 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $13,135,446 | 18,206 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,916,675 | 4,234 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,849,054 | 3,128 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $5,819,235 | 8,332 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $11,202,533 | 17,739 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $7,177,434 | 11,860 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $13,954,563 | 24,984 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $12,296,908 | 25,990 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,011,262 | 8,303 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,006,905 | 7,158 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,023,455 | 4,848 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,918,979 | 3,930 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||